Medical Condition News

RSS

Celiac patients at no increased risk for dementia, study finds

A new and comprehensive study by investigators at the Celiac Disease Center at Columbia University Medical Center has found that celiac patients are at no increased risk for dementia before or after their diagnosis of celiac disease.

20 Oct 2015

Study explores relative role of traumatization, PTSD on sexual behavior and well-being

Among 96 former Swiss indentured child laborers, 22 individuals showed post-traumatic stress disorder (PTSD) symptoms and 53 reported having experienced childhood trauma. Men reported a significantly higher prevalence of both sexual concerns and dysfunctional sexual behavior compared with women.

20 Oct 2015

NAM announces election of three new members from UC San Diego School of Medicine

The National Academy of Medicine announced today the election of three new members from University of California, San Diego School of Medicine: Napoleone Ferrara, MD; Christopher K. Glass, MD, PhD; and Roberto Malinow, MD, PhD. Election to NAM is considered among the highest honors in the fields of health and medicine.

20 Oct 2015

TSRI researchers find way to change leukemia cells into leukemia-killing immune cells

Scientists at The Scripps Research Institute have found a way to change leukemia cells into leukemia-killing immune cells. The surprise finding could lead to a powerful new therapy for leukemia and possibly other cancers.

20 Oct 2015

Takeda highlights safety, efficacy of vedolizumab for UC and CD at ACG Annual Scientific Meeting

Takeda Pharmaceuticals, U.S.A., Inc., today announced that data highlighting the efficacy and safety of vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), will be presented during the 2015 American College of Gastroenterology Annual Scientific Meeting in Honolulu, Hawaii, held on October 16-21.

20 Oct 2015

Ember Therapeutics reports initial results from BMP-7 Phase II trial in patients with moderate osteoarthritis of the knee

Ember Therapeutics, Inc., a privately held, New York-based biopharmaceutical company that is developing targeted therapies for osteoarthritis, kidney fibrosis, and other indications using Bone Morphogenetic Protein (BMP)-7, announced today initial results from the Phase II(a) trial of local BMP-7 administration in patients with moderate osteoarthritis of the knee.

20 Oct 2015

Kaiser Permanente recognizes three projects for advancing quality and patient safety to transform care

As part of Kaiser Permanente's culture of continuous improvement, the organization annually recognizes outstanding projects across the nation's largest integrated health system that advance quality and patient safety. Recently, three winners were honored for their efforts in supporting patient care through technology, advanced sepsis intervention and improving early detection of diabetic retinopathy.

20 Oct 2015

Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

In the UK there are currently over 3.5 million people who have diabetes, with a growth rate exceeding 280,000 people per year. Diabetic retinopathy is the most common complication of diabetes.

19 Oct 2015

Lexicon's telotristat etiprate improves social and physical function, emotional well-being in cancer patients

Lexicon Pharmaceuticals, Inc.'s telotristat etiprate, the first oral therapy in development for the treatment of carcinoid syndrome (CS), was associated with patient-reported improvements in social and physical function and emotional well-being according to new exit interview data from the Phase 3 TELESTAR study presented at the 2015 Neuroendocrine Tumor Society Annual Symposium in Austin, Texas.

19 Oct 2015

LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis

LEO Pharma Inc., a wholly owned U.S. subsidiary of LEO Pharma A/S, announced today that Enstilar has been approved by the U.S. Food and Drug Administration for the topical treatment of plaque psoriasis in adults 18 years of age and older.

19 Oct 2015

Sequenom enters into clinical collaboration with CU School of Medicine

Sequenom, Inc., a life sciences company committed to enabling healthier lives through the development of innovative products and services, today announced that it has entered into a clinical collaboration with the University of Colorado Denver, School of Medicine.

19 Oct 2015

Latest research on thyroid cancer to be highlighted at 15th International Thyroid Congress

The effect of radiation exposure related to the nuclear accidents that took place in Fukushima, Japan, and Chernobyl, Ukraine on thyroid cancer risk, whether dietary habits influence the risk of developing thyroid cancer, and recent study results with a triiodothyronine (T3) analog in an uncommon form of thyroid disease are all topics featured in oral presentations delivered at the 15th International Thyroid Congress, hosted by the American Thyroid Association, October 18-23, 2015, in Orlando, Florida.

19 Oct 2015

Study could lead to better understanding of metabolic processes behind type 2 diabetes

Scientists in Sweden have discovered that human intestinal flora regulates the levels of the body's main antioxidant, glutathione, which fights a host of diseases. The findings could lead to new probiotic-delivering foods, and a better understanding of the metabolic processes behind diseases such as type 2 diabetes.

19 Oct 2015

Researchers associate neuroimaging data with reading deficits in patients with left-sided stroke

Researchers at Kessler Foundation and Rutgers University correlated neuroimaging data with reading deficits in patients with subacute left hemispheric stroke. Their findings add to our knowledge of the neural mechanisms of reading and may be useful in the development of reading interventions that address specific neurological deficits.

19 Oct 2015

Pulsar Vascular reaches target enrollment in PulseRider clinical trial for treatment of intracranial aneurysms

Pulsar Vascular, an innovative medical device company, focused on breakthrough technology in the neurovascular space, announced today that they have reached the target enrollment in their clinical trial for PulseRider, the company's lead product.

19 Oct 2015

NCCN reveals new value initiative for CML and Multiple Myeloma

The National Comprehensive Cancer Network, a not-for-profit alliance of 26 of the world's leading cancer centers, today unveiled its new value initiative—the NCCN Evidence Blocks, published within new versions of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Chronic Myelogenous Leukemia (CML) and Multiple Myeloma.

19 Oct 2015

Breakthrough advancements on new molecular mechanism may lead to Parkinson's treatments

More than one million people in the United States are afflicted with Parkinson's disease, a progressive disorder of the brain that affects movement and coordination. The cause is typically unknown, and presently there is no cure for the disease.

19 Oct 2015

Immatics, UTHealth to partner on cellular manufacturing for adoptive cellular therapy clinical trials

Immatics US, Inc., a subsidiary of Immatics Biotechnologies GmbH, and The University of Texas Health Science Center at Houston will collaborate on cellular manufacturing for adoptive cellular therapy (ACT) clinical trials.

19 Oct 2015

UB study sheds light on the root causes of Huntington's disease

We've known for years that the Huntingtin protein (Htt) is responsible for Huntington's disease, a neurodegenerative disorder that diminishes a person's mental and physical abilities.

19 Oct 2015

UAMS researchers report positive results from treating Metastatic Merkel-cell carcinoma with idelalisib drug

Identifying a patient's genetic mutation led University of Arkansas for Medical Sciences (UAMS) physician-researcher Ling Gao, M.D., Ph.D., to an existing drug that eliminated the patient's stage IV Merkel-cell carcinoma. Gao's findings, made in collaboration with two other UAMS researchers, were published today in The New England Journal of Medicine.

19 Oct 2015

Medical Condition News

Celiac patients at no increased risk for dementia, study finds

Study explores relative role of traumatization, PTSD on sexual behavior and well-being

NAM announces election of three new members from UC San Diego School of Medicine

TSRI researchers find way to change leukemia cells into leukemia-killing immune cells

Takeda highlights safety, efficacy of vedolizumab for UC and CD at ACG Annual Scientific Meeting

Ember Therapeutics reports initial results from BMP-7 Phase II trial in patients with moderate osteoarthritis of the knee

Kaiser Permanente recognizes three projects for advancing quality and patient safety to transform care

Diabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix

Lexicon's telotristat etiprate improves social and physical function, emotional well-being in cancer patients

LEO Pharma's Enstilar gets FDA approval for topical treatment of plaque psoriasis

Sequenom enters into clinical collaboration with CU School of Medicine

Latest research on thyroid cancer to be highlighted at 15th International Thyroid Congress

Study could lead to better understanding of metabolic processes behind type 2 diabetes

Researchers associate neuroimaging data with reading deficits in patients with left-sided stroke

Pulsar Vascular reaches target enrollment in PulseRider clinical trial for treatment of intracranial aneurysms

NCCN reveals new value initiative for CML and Multiple Myeloma

Breakthrough advancements on new molecular mechanism may lead to Parkinson's treatments

Immatics, UTHealth to partner on cellular manufacturing for adoptive cellular therapy clinical trials

UB study sheds light on the root causes of Huntington's disease

UAMS researchers report positive results from treating Metastatic Merkel-cell carcinoma with idelalisib drug

How Pulp Fixin Is Turning Paper into High-Performance Sustainable Labware

A new method to measure intracellular water in biological systems

Obesity, GLP-1s, and metabolic care

Latest News